Business
Mesoblast (ASX:MSB) share price tumbles 8% giving back most of yesterday’s gains
Image source: Getty Images
The Mesoblast Ltd (ASX: MSB) share price was in reverse today after surging more than 11% on Monday. The allogeneic cellular medicines company announced a trial update to its rexlemestrocel-L drug.
At the closing bell, Mesoblast shares finished the day down 8.68%…
Continue Reading
-
Noosa News18 hours agoNRL live updates: Newcastle Knights vs Melbourne Storm, St George Illawarra Dragons vs Sydney Roosters, North Queensland Cowboys vs Canterbury Bulldogs
-
Noosa News19 hours agoCreating space for cultural pride – Proctor
-
Noosa News22 hours agoNASAA Certified Organic collapse threatens export capabilities for hundreds of Australian producers
-
Noosa News21 hours agoSugarcane fields reveal devastating long-term impact of north Queensland floods